Abstract
Recent research suggests that ultraviolet radiation exposure (UVRE), our major source of vitamin D, is associated with reduced lymphoma risk. Animal and human studies support an association between vitamin D (vitD) insufficiency and increased risk of some malignancies. We conducted a clinic-based case–control study (140 lymphoma cases, 139 controls; 2002–2005, Rochester, NY) to evaluate UVRE and vitD insufficiency in relation to lymphoma risk. Subjects completed a survey and provided a blood sample. We used multivariable logistic regression to estimate lymphoma risk in relation to past (5–10 years prior) UVRE and current vitD insufficiency (determined by serum 25(OH)D). Possible differences in effect by lymphoma subtype were explored, but statistical power was limited. We confirmed the previously reported decrease in lymphoma risk with past UVRE, specifically sunbathing (>once/week versus never); adjusted odds ratio (ORadj), = 0.28, 95% confidence interval (CI): 0.10–0.79. Current vitD insufficiency was not associated with lymphoma risk (ORadj = 0.89, 95% CI: 0.47–1.72). However, current sunbathing frequency was correlated with measured serum 25(OH)D values. Therefore, while our data do not support an association with current vitD status, development of accurate methods for past vitD assessment to further investigate its role in the association between past UVRE and lymphoma risk is warranted.
Similar content being viewed by others
Abbreviations
- 25(OH)D:
-
25-Hydroxyvitamin D
- CI:
-
Confidence interval
- DLBCL:
-
Diffuse large B cell lymphoma
- FL:
-
Follicular lymphoma
- NHL:
-
Non-Hodgkin lymphoma
- OR:
-
Odds ratio
- UVR:
-
Ultraviolet radiation
References
Ries L, Melbert D, Krapcho M et al. (eds.) (2005) SEER Cancer Statistics Review, 1975-2004. http://seer.cancer.gov/csr/1973_2004/. Vol. based on November 2006 SEER data submission, posted to the SEER website, 2007. 2005, National Cancer Institute: Bethesda, MD
Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534
Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1–12
Hartge P, Lim U, Freedman DM et al (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17(8):1045–1052
Soni LK, Hou L, Gapstur SM et al (2007) Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Eur J Cancer 43(16):2388–2395
Weihkopf T, Becker N, Nieters A et al (2007) Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 120(11):2445–2451
Hughes AM, Armstrong BK, Vajdic CM et al (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112(5):865–871
Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97(3):199–209
Armstrong BK, Kricker A (2007) Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):396–400
Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122(1):144–154
Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688S
Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169(6):626–632
Schwartz GG, Skinner HG (2007) Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 10(1):6–11
Egan KM, Sosman JA, Blot WJ (2005) Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 97(3):161–163
Holick MF (2008) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19(2):73–78
Holick MF (2003) Vitamin D: a millenium perspective. J Cell Biochem 88(2):296–307
Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79(3):362–371
DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696S
Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs–a brief overview. Mol Cell Biochem 253(1–2):247–254
Hickish T, Cunningham D, Colston K et al (1993) The effect of 1, 25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 68(4):668–672
Raina V, Cunningham D, Gilchrist N, Soukop M (1991) Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 63(3):463–465
Chang ET, Balter KM, Torrang A et al (2006) Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol 164(12):1222–1232
Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 17(4):713–718
Purdue MP, Hartge P, Davis S et al (2007) Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 18(9):989–999
Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98(7):451–459
Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594–1602
Lim U, Freedman DM, Hollis BW et al (2009) A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124(4):979–986
Erber E, Maskarinec G, Lim U, Kolonel LN (2009) Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort. Br J Nutr 103(4):581–584
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281
Tanner JT, Smith J, Defibaugh P et al (1988) Survey of vitamin content of fortified milk. J Assoc Off Anal Chem 71(3):607–610
Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849
Kulak CA, Borba VZ, Bilezikian JP et al (2004) Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 62(4):940–948
Holick MF, Siris ES, Binkley N et al (2005) Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90(6):3215–3224
Brown LM, Hoover R, Gridley G et al (1997) Drinking practices and risk of squamous-cell esophageal cancer among Black and White men in the United States. Cancer Causes Control 8(4):605–609
Brown LM, Pottern LM, Silverman DT et al (1997) Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control 8(4):610–614
Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL (1993) Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 39(3):529–533
Stolzenberg-Solomon RZ, Hayes RB, Horst RL et al (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4):1439–1447
Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lipincott-Raven Publishers, Philadelphia, PA
Millen AE, Bodnar LM (2008) Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 87(4):1102S–1105S
Brot C, Vestergaard P, Kolthoff N et al (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 86(1):S97–S103
Al-Delaimy WK, Jansen EH, Peeters PH et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11(4):370–382
Davies M, Hayes ME, Yin JA, Berry JL, Mawer EB (1994) Abnormal synthesis of 1, 25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 78(5):1202–1207
Morton LM, Wang SS, Cozen W et al (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160
Evens AM, Chiu BC (2008) The challenges of epidemiologic research in non-Hodgkin lymphoma. JAMA 300(17):2059–2061
Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC (2007) What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65(8 Pt 2):S91–S95
Crew KD, Gammon MD, Steck SE et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa) 2(6):598–604
Weiss RA (2004) Multistage carcinogenesis. Br J Cancer 91(12):1981–1982
Vermeer M, Schmieder GJ, Yoshikawa T et al (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol 97(4):729–734
Hersey P, Bradley M, Hasic E et al (1983) Immunological effects of solarium exposure. Lancet 1(8324):545–548
Melbye M, Adami HO, Hjalgrim H, Glimelius B (1996) Ultraviolet light and non-Hodgkin’s lymphoma. Acta Oncol 35(6):655–657
Fisher SG, Fisher RI (2006) The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 18(5):417–424
Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):401–404
Steindal AH, Porojnicu AC, Moan J (2007) Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses 69(1):182–185
Acknowledgments
This work was supported by a hematology training grant award from the National Institutes of Health, National Heart Lung and Blood Institute [T32 HL007152]; the Leukemia and Lymphoma Society Clinical Scholar Program; the National Institutes of Health, National Center for Research Resources [UL 1 RR024160]; and the National Institutes of Health, National Cancer Institute [K23 CA102216 and P50 CA130805]. The authors declare no competing financial interests, corporate involvement, or patent holdings. The authors alone are responsible for the content and writing of the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kelly, J.L., Friedberg, J.W., Calvi, L.M. et al. A case–control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults. Cancer Causes Control 21, 1265–1275 (2010). https://doi.org/10.1007/s10552-010-9554-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9554-1